Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
Recruiting · NCT05094570 · Registry updated 2025-04-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP | Bacterial Infections and Mycoses, Infections, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, bacterial infectious disease, gram-positive bacterial infections, nasal cavity polyp, nasal disorder, otorhinolaryngologic disease, polyp, respiratory system disorder, staphylococcal infection | Recruiting | Phase 4 | 2025-04-01 | NCT05094570 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Regeneron Pharmaceuticals | 238 |
| University of Virginia | 201 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Virginia Health System | Charlottesville | United States | 57 |